Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where David W. Gordon is active.

Publication


Featured researches published by David W. Gordon.


Bioorganic & Medicinal Chemistry Letters | 1995

Reductive alkylation on a solid phase: Synthesis of a piperazinedione combinatorial library

David W. Gordon; John Steele

Abstract The synthesis of a prototype trisubstituted piperazinedione combinatorial library of 1,000 compounds has been achieved from three precursor sets — two sets of ten α-amino acids and one set of ten aldehydes. A sodium triacetoxyborohydride-mediated reductive alkylation was crucial to the success of the multi-step synthesis on resin. This protocol represents a new method to augment compound files rapidly with novel heterocyclic entities for high-speed screening.


Bioorganic & Medicinal Chemistry Letters | 1995

The combinatorial synthesis of a 30,752-compound library: discovery of SAR around the endothelin antagonist, FR-139,317

Nicholas K. Terrett; Dejan Bojanic; David Brown; Peter J. Bungay; Mark Gardner; David W. Gordon; Carolyn J. Mayers; John Steele

Abstract A combinatorial library of 30,752 compounds has been synthesised from a set of 32 natural and unnatural amino acids. The library was designed to include the known endothelin antagonist, FR-139,317, as a positive control, and this and a number of close analogues were shown to be the most potent compounds. Thus, combinatorial libraries may be used both to discover leads and rapidly explore SAR. A combinatorial library of 30,752 compounds has been synthesised from a set of 32 natural and unnatural amino acids. The library was designed to include the known endothelin antagonist, FR-139,317, as a positive control, and this and a number of close analogues were shown to be the most potent compounds. Thus, combinatorial libraries may be used both to discover leads and rapidly explore SAR.


Bioorganic & Medicinal Chemistry Letters | 2009

Design and synthesis of piperazinylpyrimidinones as novel selective 5-HT2c agonists

Mark David Andrews; Martin P. Green; Charlotte Moira Norfor Allerton; David V. Batchelor; Julian Blagg; Alan Daniel Brown; David W. Gordon; Gordon McMurray; Daniel J. Millns; Carly L. Nichols; Lesa Watson

This Letter reports the design and synthesis of several novel series of piperazinyl pyrimidinones as 5-HT(2C) agonists. Several of the compounds presented exhibit good in vitro potency and selectivity over the closely related 5-HT(2A) and 5-HT(2B) receptors. Compound 11 was active in in vivo models of stress urinary incontinence.


Bioorganic & Medicinal Chemistry Letters | 2009

The design and discovery of novel amide CCR5 antagonists.

David C. Pryde; Martin Corless; David R. Fenwick; Helen J. Mason; Blanda L.C. Sandwich Stammen; Peter T. Stephenson; David Ellis; David Bachelor; David W. Gordon; Christopher Gordon Barber; Anthony Wood; Donald Stuart Middleton; David C. Blakemore; Gemma C. Parsons; Rachel L. Eastwood; Michelle Y. Platts; Keith Statham; Kerry A. Paradowski; Catherine Burt; Wolfgang Klute

The synthesis of a range of novel amine-containing structures and their primary potency as inhibitors of HIV-1 fusion via blocking of the CCR5 receptor is described. The development of the medicinal chemistry strategy and SARs which led to the identification of the piperidine amide compounds 33 and 36 as excellent leads for further evaluation is described, along with key physicochemical data which highlighted their lead potential.


Synthetic Communications | 1985

A Convenient Route to Tropolone Ethers

R. J. Bass; David W. Gordon

Abstract A general synthesis of tropolone ethers employing the reaction of tropolone with potassium carbonate, an alkyl halide and dicyclohexyl-18-crown-6 in acetonitrile solvent is described.


Bioorganic & Medicinal Chemistry Letters | 2009

Design and optimisation of selective serotonin re-uptake inhibitors with high synthetic accessibility: part 2.

Mark David Andrews; Alan Daniel Brown; Jean-Yves Chiva; David Sebastien Fradet; David W. Gordon; Mark Ian Lansdell; Malcolm MacKenny

A second wave of potential SSRIs with high ease of synthetic accessibility were designed based on the reported selective serotonin re-uptake inhibitor litoxetine and our own previous work in this area. Preparation and subsequent optimisation yielded a range of potent and highly selective SSRIs.


Synthetic Communications | 2010

Expeditious One-Pot, Four-Step Preparation of 2-t-Butoxycarbonyl-6-hydroxy-1,2,3,4-tetrahydroisoquinoline and an Improved Conversion to Its 6-Cyano Derivative

David W. Gordon; Carol A. Bains

3-Methoxy-phenethylamine was subjected to a sequential imination/Pictet–Spengler/demethylation/Boc protection sequence that allowed a one-pot preparation of N-Boc-6-hydroxy-1,2,3,4-tetrahydroisoquinoline 1. This intermediate was elaborated almost quantitatively via an improved triflation/cyanation procedure to its 6-cyano analog 2.


Tetrahedron | 1995

COMBINATORIAL SYNTHESIS : THE DESIGN OF COMPOUND LIBRARIES AND THEIR APPLICATION TO DRUG DISCOVERY

Nicholas K. Terrett; Mark Gardner; David W. Gordon; Ryszard Jurek Kobylecki; John Steele


Chemistry: A European Journal | 1997

Drug Discovery by Combinatorial Chemistry—the Development of a Novel Method for the Rapid Synthesis of Single Compounds†

Nicholas K. Terrett; Mark Gardner; David W. Gordon; Ryszard Jurek Kobylecki; John Steele


Archive | 2004

Amide derivatives as selective serotonin re-uptake inhibitors

Mark David Andrews; Alan Daniel Brown; David Sebastien Fradet; David W. Gordon; Mark Ian Lansdell; Malcolm MacKenny

Researchain Logo
Decentralizing Knowledge